{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:03:51Z","timestamp":1774483431786,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,25]]},"DOI":"10.7759\/cureus.79624","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T13:46:27Z","timestamp":1740491187000},"source":"Crossref","is-referenced-by-count":1,"title":["Robotic Resection of Colonic Medullary Carcinoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Justin M","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-023-04160-0","article-title":"Colonic medullary carcinoma: an exceedingly rare type of colorectal malignancy: a\u00a0case report and review of the\u00a0literature","volume":"17","author":"Al-Ishaq F","year":"2023","unstructured":"Al-Ishaq F, Al-Dhaheri M, Toffaha A, Awad S, Rizvi S, AbuNada M, Kurer M. Colonic medullary carcinoma: an exceedingly rare type of colorectal malignancy: a\u00a0case report and review of the\u00a0literature. J Med Case Rep. 2023, 17:434. 10.1186\/s13256-023-04160-0","journal-title":"J Med Case Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50674","article-title":"Stage II medullary carcinoma of the colon: a surgery case report","volume":"15","author":"Plummer PD","year":"2023","unstructured":"Plummer PD, Yglesias B, Giuseppucci P. Stage II medullary carcinoma of the colon: a surgery case report. Cureus. 2023, 15:e50674. 10.7759\/cureus.50674","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15831","article-title":"Medullary carcinoma of the colon: a histopathologic challenge","volume":"13","author":"Fatima Z","year":"2021","unstructured":"Fatima Z, Sharma P, Youssef B, Krishnan K. Medullary carcinoma of the colon: a histopathologic challenge. Cureus. 2021, 13:e15831. 10.7759\/cureus.15831","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2008.08.014","article-title":"Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation","volume":"40","author":"Winn B","year":"2009","unstructured":"Winn B, Tavares R, Fanion J, Noble L, Gao J, Sabo E, Resnick MB. Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation. Hum Pathol. 2009, 40:398-404. 10.1016\/j.humpath.2008.08.014","journal-title":"Hum Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000741","article-title":"Medullary carcinoma of the large intestine: a population based analysis","volume":"37","author":"Thirunavukarasu P","year":"2010","unstructured":"Thirunavukarasu P, Sathaiah M, Singla S, et al.. Medullary carcinoma of the large intestine: a population based analysis. Int J Oncol. 2010, 37:901-7. 10.3892\/ijo_00000741","journal-title":"Int J Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.084","article-title":"Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer","volume":"20","author":"Schrag D","year":"2002","unstructured":"Schrag D, Rifas-Shiman S, Saltz L, Bach PB, Begg CB. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol. 2002, 20:3999-4005. 10.1200\/JCO.2002.11.084","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.8.2429","article-title":"Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival","volume":"17","author":"Lanza G","year":"1999","unstructured":"Lanza G, Gaf\u00e0 R, Matteuzzi M, Santini A. Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival. J Clin Oncol. 1999, 17:2429-38. 10.1200\/JCO.1999.17.8.2429","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27935","article-title":"Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer","volume":"119","author":"Boland GM","year":"2013","unstructured":"Boland GM, Chang GJ, Haynes AB, et al.. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer. 2013, 119:1593-601. 10.1002\/cncr.27935","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0021","article-title":"NCCN Guidelines insights: colon cancer, version 2.2018","volume":"16","author":"Benson AB","year":"2018","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al.. NCCN Guidelines insights: colon cancer, version 2.2018. J Natl Compr Canc Netw. 2018, 16:359-69. 10.6004\/jnccn.2018.0021","journal-title":"J Natl Compr Canc Netw"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.12.2936","article-title":"Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II\/Dukes' B2 colon cancer","volume":"13","author":"Moertel CG","year":"1995","unstructured":"Moertel CG, Fleming TR, Macdonald JS, et al.. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II\/Dukes' B2 colon cancer. J Clin Oncol. 1995, 13:2936-43. 10.1200\/JCO.1995.13.12.2936","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andr\u00e9 T","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, et al.. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004, 350:2343-51. 10.1056\/NEJMoa032709","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37337","article-title":"A review of robotic surgery in colorectal surgery","volume":"15","author":"Ravendran K","year":"2023","unstructured":"Ravendran K, Abiola E, Balagumar K, et al.. A review of robotic surgery in colorectal surgery. Cureus. 2023, 15:e37337. 10.7759\/cureus.37337","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/344243-robotic-resection-of-colonic-medullary-carcinoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T13:46:29Z","timestamp":1740491189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/344243-robotic-resection-of-colonic-medullary-carcinoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.79624","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,25]]}}}